The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, December 03, 2021
Noramco, LLC, a leading North American producer of controlled substance bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry,...
read more
Monday, December 06, 2021
NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced a ...
read more
Monday, December 06, 2021
Longeveron Inc., a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening ...
read more
Monday, December 06, 2021
Merck announced that the FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric (12 years and older) ...
read more
Monday, December 06, 2021
Merck has entered into a Supply Agreement with the Government of Canada for up to 1 million patient courses of molnupiravir, its investigational oral ...
read more
Tuesday, December 07, 2021
AstraZeneca has entered into a new global development and commercialization agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, ...
read more
Tuesday, December 07, 2021
Sosei Group Corporation announced it has received grant funding from Wellcome, through the COVID-19 Therapeutics Accelerator.
read more
Tuesday, December 07, 2021
ATP (Apple Tree Partners), a life sciences venture capital company, announced the launch of Adendra Therapeutics Ltd., a company that will discover ...
read more
Tuesday, December 07, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline announced positive efficacy and safety results from the global...
read more
Tuesday, December 07, 2021
Merck announced an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world ...
read more
Tuesday, December 07, 2021
Merck announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 (MK-8591-024) Phase 3 clinical studies evaluating ...
read more
Wednesday, December 08, 2021
Nuvation Bio Inc. announced that the FDA has cleared its investigational new drug (IND) application to evaluate NUV-422, a cyclin-dependent kinase (...
read more
Wednesday, December 08, 2021
LYVISPAH™ (lye-vis'-pah) is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms ...
read more
Wednesday, December 08, 2021
Pfizer Inc. and BioNTech SE announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech ...
read more
Wednesday, December 08, 2021
Shanghai Pharmaceuticals and Syntegon have signed an agreement to build a laboratory for continuous manufacturing technology in China. The cooperation...
read more